Migration of Implant
Conditions
Brief summary
New endoscopic clipping device called the over-the-scope-clip (OTSC) system (Ovesco Endoscopy, Tübingen, Germany) has become available for the closure of perforations, anastomotic leaks, and fistulas. The OTSC system has a stronger closing force than the through-the-scope hemostatic clip. Therefore, some researchers have reported esophageal SEMS fixation with an OTSC to prevent migration.
Detailed description
Participants requiring esophageal SEMS placement for various indications such as stricture (benign, malignant), leaks All participants who require esophageal SEMS placement. Esophago-gastroscopy will be done to assess the feasibility of SEMS placement. Participants are randomized into two arms- one arm (interventional) use of OTSC stent fix after esophageal SEMS placement or the other arm (non-interventional) esophageal SEMS is placed. Participants are followed up for 1 year to observe stent migration rate in both the groups.
Interventions
A stent that of at least 4 cm longer than the stricture will be used to allow at least a 2-cm extension above and below the proximal and distal tumor margins. The stent positioned over a guidewire and deployed under fluoroscopy guidance and, in some cases, also under endoscopy guidance. Subsequently, the OTSC system will be loaded onto the scope and part of the upper rim of the stent will be suctioned into the transparent cap before releasing the OTSC, grasping both the SEMS and esophageal wall. We will avoid deploying the OTSC in areas of pulsations to prevent potential grasping of the vasculature structure
Sponsors
Study design
Intervention model description
A new endoscopic clipping device called the over-the-scope-clip (OTSC) system (Ovesco Endoscopy, Tübingen, Germany) has become available for the closure of perforations, anastomotic leaks, and fistulas. The OTSC system has a stronger closing force than the through-the-scope hemostatic clip. Therefore, some researchers have reported esophageal SEMS fixation with an OTSC to prevent migration
Eligibility
Inclusion criteria
* All adults (18+ years) * Have benign, malignant non-stricture esophageal lesions (i.e. fistulae, perforation, leaks) warranting esophageal stent placement as an inpatient or outpatient * Ability to consent to stent fixation.
Exclusion criteria
* Patients aged under 18 years of age * Unable to provide informed consent * Inherited or acquired coagulopathy likely to affect the risk of bleeding * Receiving anticoagulant therapy that could not be stopped or bridged prior to procedure * Breast feeding, pregnant and lactating women's.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Esophageal SEMS migration rate at 4 weeks follow up. | 4 weeks | Proportion of patients experiencing stent migration at 4 weeks after index procedure. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Procedural time in minutes | immediately after procedure | Total time required to complete the intended procedure |
| Migration of stent in both groups | 6 months | Time to migration after stent placement in respective groups |
| Adverse events in both groups apart from stent migration | 6 months | All the adverse events will be recorded, excluding SEMS migration, which is already an primary outcome measure separately |
| Improvement in dysphagia score | 1 week | Improvement in dysphagia score at one week post procedure in both the arms |